Showing results (231-240 of 361) with videos related to

Sort By:
Pageof 37
Blood|May 1, 1988
Use of a monoclonal antibody (GA3) to demonstrate lineage restricted O-glycosylation on leukosialin during terminal erythroid differentiationA Bettaieb, F Farace, M T Mitjavila, et al.
European Heart Journal|March 1, 1991
Non-Hodgkin's lymphoma with cardiac presentation: evaluation and follow-up with echocardiography and MR imagingJ J Monsuez, J Frija, L Hertz-Pannier, et al.
Hematological Oncology|January 1, 1990
Treatment of low-grade non-Hodgkin's lymphomas: assessment of doxorubicin in a controlled trialE Lepage, C Sebban, C Gisselbrecht, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1984
[Acute promyelocytic leukemia: retrospective study of 119 patients treated with daunorubicin]M Marty, G Ganem, J Fischer, et al.
Morphologie : Bulletin De L'Association Des Anatomistes|August 26, 2006
[Experimental study of the influence of the segmental transverse colic reversion on the intestinal transit time]B D Kouame, A Brou, H Lardy, et al.
La Nouvelle Presse Medicale|October 3, 1981
[Autoimmune thrombocytopenic purpura. Clinical and therapeutic retrospective study of 544 cases (author's transl)]G Tobelem, C Chastang, B Asselain, et al.
Cancer|February 1, 1976
Clinical study of rubidazone (22 050 R.P.), a new daunorubicin-derived compound, in 170 patients with acute leukemias and other malignanciesC Jacquillat, M Weil, M F Gemon-Auclerc, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|October 27, 1983
[Herpesvirus infections during treatment inducing remission of acute leukemia]M Marty, C Pontus, C Scieux, et al.
British Journal of Haematology|April 1, 1985
Complete correction of Glanzmann's thrombasthenia by allogeneic bone-marrow transplantationS Bellucci, A Devergie, E Gluckman, et al.
The Journal of Clinical Investigation|September 1, 1988
Predominant expression of circulating CD3+ lymphocytes bearing gamma T cell receptor in a prolonged immunodeficiency after allogeneic bone marrow transplantationE Vilmer, P Guglielmi, V David, et al.
Pageof 37